Tag: antiviral therapy

Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations

This 2021 review article explores the potential of methylene blue (MB) as a therapeutic agent for COVID-19, focusing on its mechanisms of action and clinical investigations. MB exhibits multiple antiviral and immunomodulatory properties: it can inhibit SARS-CoV-2 replication by interfering with the viral spike protein’s binding to ACE2 receptors, disrupt

Read More »

Intravenous ozonized saline therapy as prophylaxis for healthcare workers (HCWs) in a dedicated COVID-19 hospital in India – A retrospective study

This retrospective controlled cohort study evaluated the use of intravenous ozonized saline as a prophylactic treatment for COVID-19 in healthcare workers (HCWs). A total of 235 HCWs were divided into two groups: 64 received ozone therapy in addition to standard prophylaxis, while 171 received only standard care. The results showed

Read More »

Molecular effects of ozone on amino acids and proteins, especially human hemoglobin and albumin, and the need to personalize ozone concentration in major ozone autohemotherapy

This retrospective controlled cohort study evaluated intravenous (IV) ozonized saline therapy as a prophylactic intervention for healthcare workers (HCWs) in a COVID-19 hospital in India. Among 235 HCWs, 64 received ozone therapy in addition to standard prophylaxis, while 171 received standard prophylaxis only. The incidence of COVID-19 was significantly lower

Read More »

Ozone therapy in COVID-19: A narrative review

This 2021 narrative review titled “Ozone therapy in COVID-19: A narrative review” (Virus Research, DOI: [10.1016/j.virusres.2020.198207*) assessed the potential role of ozone therapy as an adjunctive treatment for COVID-19. The authors discussed how ozone’s antiviral, anti-inflammatory, immunomodulatory, and oxygenation-enhancing properties could theoretically target key pathophysiological processes like cytokine storms and

Read More »